Joan E Hilner
Overview
Explore the profile of Joan E Hilner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pereira M, Jacobs Jr D, Slattery M, Ruth K, Van Horn L, Hilner J, et al.
CVD Prev
. 2019 Jan;
1(3):231-242.
PMID: 30636864
Background: Whole grain consumption may influence insulin through beneficial effects on satiety and body weight, intestinal absorption, or the action of specific nutrients or constituents. Design And Methods: We examined...
2.
Morahan G, Mehta M, James I, Chen W, Akolkar B, Erlich H, et al.
Diabetes
. 2011 Jan;
60(3):1030-40.
PMID: 21266329
Objective: Interactions between genetic and environmental factors lead to immune dysregulation causing type 1 diabetes and other autoimmune disorders. Recently, many common genetic variants have been associated with type 1...
3.
Bingley P, Williams A, Colman P, Gellert S, Eisenbarth G, Yu L, et al.
Clin Trials
. 2010 Aug;
7(1 Suppl):S56-64.
PMID: 20693189
Background: and Purpose: Three network laboratories measured antibodies to islet autoantigens. Antibodies to glutamic acid decarboxylase (GAD65 [GADA]) and the intracellular portion of protein tyrosine phosphatase (IA-2(ic) [IA-2A]) were measured...
4.
Hall M, King N, Perdue L, Hilner J, Akolkar B, Greenbaum C, et al.
Clin Trials
. 2010 Aug;
7(1 Suppl):S33-45.
PMID: 20693188
Background: and Purpose: This article describes several ethical, legal, and social issues typical of international genetics biobanking, as encountered in the Type 1 Diabetes Genetics Consortium (T1DGC). Methods: By studying...
5.
Perdue L, Albret L, Aldrich A, Loth A, Sides E, Dove A, et al.
Clin Trials
. 2010 Jul;
7(1 Suppl):S46-55.
PMID: 20603249
Background: When collecting phenotypic data in clinics across the globe, the Type 1 Diabetes Genetics Consortium (T1DGC) used several techniques that ensured consistency, completeness, and accuracy of the data. Purpose:...
6.
Hilner J, Perdue L, Sides E, Pierce J, Wagner A, Aldrich A, et al.
Clin Trials
. 2010 Jul;
7(1 Suppl):S5-S32.
PMID: 20603248
Background And Purpose: The Type 1 Diabetes Genetics Consortium (T1DGC) is an international project whose primary aims are to: (a) discover genes that modify type 1 diabetes risk; and (b)...
7.
Rosinger S, Nutland S, Mickelson E, Varney M, Boehm B, Olsem G, et al.
Clin Trials
. 2010 Jul;
7(1 Suppl):S65-74.
PMID: 20595244
Background: and Purpose: To yield large amounts of DNA for many genotype analyses and to provide a renewable source of DNA, the Type 1 Diabetes Genetics Consortium (T1DGC) harvested DNA...
8.
Mychaleckyj J, Noble J, Moonsamy P, Carlson J, Varney M, Post J, et al.
Clin Trials
. 2010 Jul;
7(1 Suppl):S75-87.
PMID: 20595243
Background: Although human leukocyte antigen (HLA) DQ and DR loci appear to confer the strongest genetic risk for type 1 diabetes, more detailed information is required for other loci within...
9.
Concannon P, Chen W, Julier C, Morahan G, Akolkar B, Erlich H, et al.
Diabetes
. 2009 Jan;
58(4):1018-22.
PMID: 19136655
Objective: Type 1 diabetes arises from the actions of multiple genetic and environmental risk factors. Considerable success at identifying common genetic variants that contribute to type 1 diabetes risk has...
10.
Concannon P, Onengut-Gumuscu S, Todd J, Smyth D, Pociot F, Bergholdt R, et al.
Diabetes
. 2008 Jul;
57(10):2858-61.
PMID: 18647951
Objective: The Type 1 Diabetes Genetics Consortium (T1DGC) has assembled and genotyped a large collection of multiplex families for the purpose of mapping genomic regions linked to type 1 diabetes....